跳至主要内容
临床试验/NL-OMON37136
NL-OMON37136已完成2 期

The effect of intranasal insulin on development and behaviour of children with Phelan-McDermid syndrome - Intranasal insulin in PMS

niversitair Medisch Centrum Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • Age between 12 months and 18 years 0 months old at 1-1-2013
  • Proven SHANK3 deletion by array-comparative genomic hybridization (array-CGH)
  • Parents need to speak and understand Dutch

排除标准

  • A contra-indication for the use of intranasal application (e.g. anatomical obstruction)
  • Severe perinatal brain damage (e.g. asphyxia, haemorrhage, infection)
  • A metabolic or muscle disease responsible for neurological symptoms, independent of the 22q13 deletion

研究者

相似试验

The effect of intranasal insulin on development and... | 临床试验